Fund shareholders of ENVERIC BIOSCIENCES INC
ISIN US29405E5050 · United States · LEI 549300CATCWKUQ6G5854
- Fund shareholders
- 4
- Of which ETFs
- 1 3 other funds
- Value held
- 52.4K $
- Share of capital
- 0.6 % of 4.5M shares on Aug 12, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 16,974 | 32.9K $ | 0.16 % | 0.38 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 6,968 | 16.4K $ | 0.16 % | as of Feb 28, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 911 | 2.1K $ | 0.02 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 388 | 911.8 $ | 0.01 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 0.16 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 4 | 0 | 25,241 | +30.7 % |
| 2026Q1 | 4 | 19,316 |
Institutional managers
11 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 32,149 | 62.4K $ | as of Mar 31, 2026 |
| AdvisorShares Investments LLC | 16,974 | 32.9K $ | as of Mar 31, 2026 |
| UBS Group AG | 3,612 | 7K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 1,103 | 2.1K $ | as of Mar 31, 2026 |
| JONES FINANCIAL COMPANIES LLLP | 1,000 | 1.9K $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 83 | 161 $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 51 | 99 $ | as of Mar 31, 2026 |
| NATIONAL BANK OF CANADA /FI/ | 1 | 2 $ | as of Mar 31, 2026 |
| GROUP ONE TRADING LLC | 1 | 2 $ | as of Mar 31, 2026 |
| DANSKE BANK A/S | 1 | 2 $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 1 | 2 $ | as of Mar 31, 2026 |
Declared shareholders of ENVERIC BIOSCIENCES INC
1 beneficial ownership filing. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Lind Global Fund III LP and 2 others | 7.87 % | 161,232 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of ENVERIC BIOSCIENCES INC". https://titelia.com/en/stocks/enveric-biosciences-inc-US29405E5050